← Back to Vaccine Database

ARCT-154 mRNA Vaccine

RNA based vaccine · VDDBV0092

Target & Classification

SARS-CoV-2SARS-CoV-2
RNA based vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT05037097 Phase 2COVID-19
NCT05012943 Phase 3COVID-19